did not report enrichment of shRNA-Btla B cells over control B cells in BM chimeras, making it seem unlikely that cis HVEM-BTLA interaction could be the principle mechanism of HVEM-mediated tumor suppression. This evidence concerns the gene BTLA and neoplasm.